Navigation Links
AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY'
Date:8/23/2007

diagnostic method currently available for appendicitis.

The first generation of this new blood screen test system holds the potential to greatly enhance the emergency room triage process of determining which, of the millions of patients in the US annually entering emergency rooms with abdominal pain, are high risk candidates for appendicitis and require more significant diagnostic work-ups such as CT scanning. In addition to improving the overall diagnostic process surrounding this common condition in the ER, this new blood-based test could save potentially billions of dollars in unnecessary CT scans and appendicitis surgeries in the US alone.

With the AppyScore emergency room triage test and its sister product, AppyScreen(TM), designed for physician offices, AspenBio is targeting an overwhelming need for more accurate, faster, and more economical assessment of the appendicitis condition. They are anticipated to be the first and only such tests available. The company has initiated the FDA application process and anticipates a fall 2007 initial regulatory filing. The FDA approval process for diagnostic tests is typically much shorter than for drugs, and if successfully completed and approved, management's estimates suggest a worldwide, several hundred million dollar annual market potential. The patent portfolio for the AppyScore/AppyScreen appendicitis diagnostic technologies has also been significantly expanded over recent months.

About the NASDAQ

NASDAQ is the largest U.S. equities exchange operated by The Nasdaq Stock Market, Inc. (Nasdaq: NDAQ). With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companie
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Thomson Reuters today announced ... first drug pipeline database to fully integrate detailed ... anticipated new content is being provided to all ... Thomson Pharma will offer drug related ... conferences, and other sources across all therapeutic areas. ...
(Date:12/14/2009)... Calif., Dec. 14 Array BioPharma Inc. ... AMGN ) today announced that they entered into ... Array,s small-molecule glucokinase activator program, including ARRY-403, currently ... in patients with Type 2 diabetes. ... will receive an upfront payment of $60 million ...
(Date:12/14/2009)... State Biotech Leaders to Develop Blueprint to ... while Boosting Rhode Island,s Growing Biotech and ... Dec. 14 Several of Rhode ... and biotechnology gathered today at Brown University,s ... of medical innovation in Rhode Island and ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... to the demand in food, beverage and nutritional ... chemical company, Albemarle Corporation, (NYSE: ALB ... joined forces to scale-up production of Zymes, proprietary ... technology promotes the clear dissolution of non-water-soluble vitamins ...
... Provides Ease, Efficacy and Excellent TolerabilityCORONA, Calif., Jan. 27 ... a leader in generic and specialty branded pharmaceuticals, announced ... has approved GELNIQUE(TM) (oxybutynin chloride) Gel 10%, the first ... bladder (OAB) with symptoms of urge urinary incontinence, urgency, ...
... Inc. (Nasdaq: ENCO ) , a full ... development, and management capabilities for clinical trials and patient ... today announced the signing of $3.1 million of new ... current U.S. oncology clinical trial with a major global ...
Other Biology Technology:Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 2Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 3Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 2Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 3Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder 4Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 2Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 3
(Date:12/14/2009)... Society (BMES) have founded a new journal Cardiovascular ... CVET is a forum for research on all ... first issue of the new quarterly journal will appear ... at Springer, Annals of Biomedical Engineering and ... Engineering and Technology will present a wide spectrum ...
(Date:12/14/2009)... Convention on Climate Change taking place in Copenhagen, ... Trend, event on Sunday evening to provide a ... of the new ,Environmental Atlas of Europe,. , ... of the European Environment Agency (EEA), the UN ... of short films showing the significance of environmental ...
(Date:12/13/2009)... team led by Yale University researchers has used ... for the first time. Their findings, which appear ... Nature Nanotechnology , could dramatically simplify the ... other diseases. , The teamled by ... & Applied Science, and Tarek Fahmy, an associate ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2'Environmental Atlas of Europe' unveiled at COP15 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Hoag Hospital Certified as Baby Friendly Facility 52982 1Hoag Hospital Certified as Baby Friendly Facility 52982 2Hoag Hospital Certified as Baby Friendly Facility 52982 3Test helps in fight against lung infections and for treating other life threatening infections 9399 1Test helps in fight against lung infections and for treating other life threatening infections 9399 2Test helps in fight against lung infections and for treating other life threatening infections 9399 3Photos 3A Compete Releases Top Insurance and Physician Web Sites for June 2009 52976 1Photos 3A Compete Releases Top Insurance and Physician Web Sites for June 2009 52976 2Photos 3A Compete Releases Top Insurance and Physician Web Sites for June 2009 52976 3Photos 3A Compete Releases Top Insurance and Physician Web Sites for June 2009 52976 4
... movement is defined has profound implications for where evangelicals ... by sociologists at Rice University and the University of ... debate over whether Sen. Obama can shave off enough ... D. Michael Lindsay, one of the researchers. "That depends ...
... the University of York have discovered a ,Chemical Equator, ... from the largely uncontaminated atmosphere of the Southern Hemisphere. ... evidence for an atmospheric chemical equator around 50 km ... findings show for the first time that the chemical ...
... (TSC) is yielding insight into a possible cause of ... cells. Researchers in the F.M. Kirby Neurobiology Center at ... and Xi He, PhD, also found that normal neuronal ... could be done safely in humans, it might be ...
Other Biology News:New study looks to define evangelicals and how they affect polling 2'Chemical equator' discovery will aid pollution mapping 2Rare genetic disorder gives clues to autism, epilepsy, mental retardation 2
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Phenytoin-BSA Isolated IgY DFc Drug...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
Biology Products: